Elanco Animal Health (ELAN) reported Q1 adjusted earnings Wednesday of $0.37 per diluted share, up from $0.34 a year earlier. Analysts polled by FactSet expected $0.31.
Revenue for the quarter ended March 31 was $1.19 billion compared with $1.21 billion a year earlier. Analysts expected $1.17 billion.
Shares of the company rose 3.5% in recent premarket activity as Elanco increased its annual revenue guidance to a range of $4.51 billion to $4.58 billion from the prior view of $4.45 billion to $4.51 billion. Analysts polled by FactSet expect $4.48 billion. The company held its 2025 adjusted earnings guidance of $0.80 to $0.86 per share.
For Q2, the company expects adjusted EPS of $0.17 to $0.21 and revenue of $1.18 billion to $1.20 billion. Analysts surveyed by FactSet expect adjusted earnings of $0.25 per share on revenue of $1.17 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.